COM:TONIXPHARMA
Tonix Pharmaceuticals
- Stock
Last Close
0.19
21/11 21:00
Market Cap
6.10M
Beta: -
Volume Today
76.42M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -505.50K - | -4.32M 754.40% | -7.68M 77.74% | -7.88M 2.71% | -3.77M 52.22% | |||||||
average payables | 795.42K - | 1.13M 41.56% | 2.27M 101.42% | 1.96M 13.56% | 1.08M 44.71% | 1.35M 24.54% | 2.24M 65.70% | 3.83M 71.39% | 8.94M 133.18% | 10.68M 19.41% | 4.03M 62.21% | |
average receivables | 1.41M - | 1.61M 13.87% | 443K 72.47% | 509.50K 15.01% | 768K 50.74% | 4.32M 462.37% | 7.68M 77.74% | 7.88M 2.71% | 4.02M 48.99% | |||
book value per share | 224.55K - | 668.37K 197.65% | 428.32K 35.92% | 130.06K 69.64% | 62.96K 51.59% | 14.56K 76.87% | 1.17K 91.96% | 185.32 84.17% | 120.04 35.22% | 5.80 95.17% | ||
capex per share | -517.24 - | -5.91K 1,042.10% | -2.53K 57.14% | -338.46 86.63% | -12.79 96.22% | -3.69 71.13% | -2.11 42.75% | -18.11 756.58% | -19.38 7.02% | -1.35 93.05% | -0.00 99.97% | |
capex to depreciation | -0.88 - | -8.86 904.26% | -1.48 83.32% | -0.32 78.33% | -0.07 77.71% | -0.11 55.56% | -0.65 488.46% | -317.19 48,410.68% | -706.14 122.63% | -38.43 94.56% | -1.84 95.21% | |
capex to operating cash flow | 0.00 - | 0.01 693.03% | 0.01 59.93% | 0.00 68.39% | 0.00 85.22% | 0.00 4.24% | 0.00 154.54% | 0.18 27,577.70% | 0.47 165.00% | 0.49 5.08% | 0.08 84.24% | |
capex to revenue | -1.02 - | |||||||||||
cash per share | 282.83K - | 707.11K 150.01% | 457.62K 35.28% | 133.95K 70.73% | 65.21K 51.32% | 15.41K 76.37% | 1.40K 90.92% | 162.95 88.35% | 98.06 39.82% | 3.36 96.57% | ||
days of inventory on hand | -12.80 - | -55.11 330.56% | -30.55 44.57% | -26.19 14.27% | 39.11 249.33% | |||||||
days payables outstanding | 25.65 - | 19.63 23.47% | 23.11 17.74% | 8.17 64.65% | 22.22 172.03% | 19.47 12.37% | 38.87 99.65% | 33.23 14.52% | 52.52 58.06% | 26.27 49.97% | ||
days sales outstanding | ||||||||||||
debt to assets | 0.03 - | 0.02 - | 0.01 45.70% | 0.00 70.28% | 0.00 15.14% | |||||||
debt to equity | 0.04 - | 0.04 - | 0.01 60.65% | 0.00 70.78% | 0.00 16.08% | |||||||
dividend yield | 0.46 - | 1.31 187.81% | 0.01 99.47% | 0.08 - | ||||||||
earnings yield | -0.18 - | -0.44 140.56% | -0.33 23.89% | -2.12 535.86% | -0.78 63.05% | -3.65 366.04% | -15.08 313.34% | -0.78 94.81% | -0.70 10.27% | -1.32 87.61% | -0.02 98.71% | |
enterprise value | 51.88M - | 24.89M 52.02% | 125.02M 402.33% | -611K 100.49% | 1.48M 342.72% | -17.88M 1,305.93% | -9.01M 49.62% | -11.43M 26.92% | -46.52M 306.85% | -32.27M 30.64% | 6.87B 21,382.17% | |
enterprise value over ebitda | -4.76 - | -0.90 81.11% | -2.60 188.45% | 0.02 100.60% | -0.07 544.25% | 0.68 1,075.44% | 0.31 54.00% | 0.23 27.56% | 0.50 122.62% | 0.29 42.88% | -58.01 20,251.54% | |
ev to operating cash flow | -6.09 - | -1.09 82.11% | -2.94 169.78% | 0.02 100.56% | -0.08 573.49% | 0.75 1,062.29% | 0.34 54.74% | 0.24 30.27% | 0.62 161.51% | 0.33 46.56% | -67.32 20,558.03% | |
ev to sales | 883.99 - | |||||||||||
free cash flow per share | -294.21K - | -428.87K 45.77% | -454.96K 6.08% | -191.70K 57.86% | -48.93K 74.47% | -14.76K 69.85% | -3.32K 77.50% | -120.79 96.36% | -60.85 49.63% | -4.09 93.28% | -0.01 99.84% | |
free cash flow yield | -0.14 - | -0.37 157.35% | -0.30 19.23% | -2.04 587.61% | -0.71 65.22% | -3.35 372.86% | -14.19 323.10% | -0.89 93.74% | -0.85 4.85% | -1.68 98.38% | -0.02 99.05% | |
graham net net | 206.14K - | 643.22K 212.03% | 408.29K 36.52% | 124.44K 69.52% | 60.69K 51.23% | 14.01K 76.91% | 790.94 94.36% | 144.71 81.70% | 86.94 39.92% | 2.90 96.66% | 0.00 100.00% | |
graham number | 1.38M - | 2.77M 101.39% | 2.22M 19.96% | 763.47K 65.60% | 276.63K 63.77% | 72.53K 73.78% | 9.64K 86.70% | 666.50 93.09% | 369.73 44.53% | 20.49 94.46% | ||
income quality | 0.78 - | 0.83 5.69% | 0.89 7.01% | 0.96 8.55% | 0.91 5.74% | 0.92 1.46% | 0.93 1.48% | 0.96 3.22% | 0.82 14.93% | 0.89 8.66% | 0.87 1.71% | |
intangibles to total assets | 0 - | 0 | 0.00 Infinity% | 0.00 70.91% | 0.00 2.83% | 0.00 1.65% | 0.01 80.79% | 0.00 85.17% | 0.00 59.24% | 0 100% | 0 | |
interest coverage | -2.72K - | 14.17 - | ||||||||||
interest debt per share | 9.79K - | 44.52 - | 2.77 93.77% | 0.52 81.07% | -0.20 138.14% | |||||||
inventory turnover | -28.51 - | -6.62 76.77% | -11.95 80.41% | -13.94 16.64% | 9.33 166.97% | |||||||
invested capital | 0.04 - | 0.04 - | 0.01 60.65% | 0.00 70.78% | 0.00 16.08% | |||||||
market cap | 59.80M - | 63.07M 5.48% | 144.20M 128.62% | 18.33M 87.29% | 26.98M 47.18% | 7.15M 73.50% | 1.88M 73.68% | 64.32M 3,318.07% | 131.18M 103.94% | 87.20M 33.52% | 6.87B 7,774.52% | |
net current asset value | 6.41M - | 35.59M 455.42% | 39.60M 11.29% | 24.99M 36.90% | 24.30M 2.74% | 23.40M 3.72% | 8.81M 62.36% | 77.45M 779.46% | 166.87M 115.44% | 112.27M 32.72% | 508K 99.55% | |
net debt to ebitda | 0.73 - | 1.38 89.76% | 0.40 71.16% | 0.49 22.08% | 1.20 146.37% | 0.95 20.58% | 0.38 60.28% | 1.50 296.99% | 1.93 28.35% | 1.07 44.63% | ||
net income per share | -375.31K - | -511.41K 36.26% | -511.21K 0.04% | -199.19K 61.04% | -54.02K 72.88% | -16.05K 70.28% | -3.53K 78.02% | -106.54 96.98% | -50.61 52.49% | -3.22 93.64% | -0.01 99.79% | |
operating cash flow per share | -293.69K - | -422.96K 44.02% | -452.43K 6.97% | -191.36K 57.70% | -48.92K 74.44% | -14.75K 69.85% | -3.32K 77.51% | -102.69 96.91% | -41.47 59.61% | -2.74 93.38% | -0.01 99.78% | |
payables turnover | 14.23 - | 18.60 30.67% | 15.80 15.07% | 44.69 182.91% | 16.43 63.24% | 18.75 14.12% | 9.39 49.91% | 10.99 16.99% | 6.95 36.73% | 13.89 99.90% | ||
receivables turnover | ||||||||||||
research and ddevelopement to revenue | 11.16 - | |||||||||||
return on tangible assets | -1.25 - | -0.70 43.94% | -1.02 46.71% | -1.42 38.40% | -0.79 44.07% | -1.00 25.56% | -1.97 97.41% | -0.51 73.86% | -0.38 25.47% | -0.51 33.06% | -229.64 44,966.12% | |
revenue per share | 0.00 - | |||||||||||
roe | -1.67 - | -0.77 54.22% | -1.19 55.99% | -1.53 28.32% | -0.86 43.97% | -1.10 28.48% | -3.01 173.38% | -0.57 80.93% | -0.42 26.66% | -0.56 31.66% | ||
roic | -1.60 - | -0.77 52.19% | -1.19 55.79% | -1.53 28.20% | -0.86 43.60% | -1.12 30.18% | -2.82 151.41% | -0.56 80.20% | -0.42 25.18% | -0.56 34.05% | ||
sales general and administrative to revenue | 4.47 - | |||||||||||
shareholders equity per share | 224.55K - | 668.37K 197.65% | 428.32K 35.92% | 130.06K 69.64% | 62.96K 51.59% | 14.56K 76.87% | 1.17K 91.96% | 185.32 84.17% | 120.04 35.22% | 5.80 95.17% | ||
stock based compensation to revenue | 1.19 - | |||||||||||
tangible asset value | 6.51M - | 36.09M 454.24% | 40.14M 11.22% | 25.24M 37.12% | 24.50M 2.95% | 23.54M 3.89% | 9.30M 60.51% | 87.53M 841.46% | 218.60M 149.75% | 207.18M 5.22% | 508K 99.75% | |
tangible book value per share | 224.55K - | 668.37K 197.65% | 427.04K 36.11% | 129.44K 69.69% | 62.65K 51.60% | 14.49K 76.87% | 1.17K 91.92% | 185.32 84.17% | 120.04 35.22% | 5.80 95.17% | 0.00 100.00% | |
working capital | 6.42M - | 35.65M 455.36% | 39.71M 11.37% | 25.02M 36.98% | 24.32M 2.83% | 23.40M 3.77% | 8.81M 62.34% | 78.17M 786.99% | 167.33M 114.06% | 112.60M 32.71% | 508K 99.55% |
All numbers in (except ratios and percentages)